The Amondys 45 market is witnessing steady growth over the forecast period, supported by advancements in gene-based therapies, broader newborn screening.
Read More
The Blincyto market is witnessing steady growth over the forecast period, supported by growth in precision medicine adoption, increasing approvals for immunotherapies.
Read More
The Bivigam market is witnessing steady growth over the forecast period, supported by rising prevalence of immune disorders, expansion of neurological ivig applications.
Read More
The Biothrax market is witnessing steady growth over the forecast period, supported by increased homeland security investments, rising global biodefense collaborations.
Read More
The Biorab market is witnessing steady growth over the forecast period, supported by expansion of rabies elimination goals, rising public health funding.
Read More
The Biopoin market is witnessing steady growth over the forecast period, supported by growth in chronic renal failure cases, expansion of oncology supportive care.
Read More
The Bioclate (Armour) market is witnessing steady growth over the forecast period, supported by growth of personalized hemophilia care, expansion of home infusion programs.
Read More
The Bimzelx market is witnessing steady growth over the forecast period, supported by expanding indications beyond psoriasis, increasing biologic penetration in autoimmune diseases.
Read More
The Beyfortus market is witnessing steady growth over the forecast period, supported by expanding newborn protection programs, increasing rsv awareness.
Read More
The Bexsero market is witnessing steady growth over the forecast period, supported by expansion of adolescent vaccination, increased public health funding.
Read More